Section Arrow
Quote
RAPP.NASDAQ
- Rapport Therapeutics Inc.
Quotes are at least 15-min delayed:2025/11/19 11:06 EST
Regular Hours
Last
 26.67
+1.35 (+5.33%)
Day High 
26.95 
Prev. Close
25.32 
1-M High
29.49 
Volume 
59.24K 
Bid
26.61
Ask
26.76
Day Low
25.655 
Open
25.89 
1-M Low
23.75 
Market Cap 
1.21B 
Currency USD 
P/E 21.13 
%Yield -- 
10-SMA 25.22 
20-SMA 26.07 
50-SMA 26.22 
52-W High 42.2685 
52-W Low 6.43 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.27/-3.16
Enterprise Value
1.21B
Balance Sheet
Book Value Per Share
10.73
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NUVBNuvation Bio6.55+1.75+36.46%-- 
ASBPAspire Biopharma Holdings Inc.0.0974-0.0083-7.85%-- 
OLMAOlema Pharmaceuticals22.53+2.39+11.87%-- 
CYPHCypherpunk Technologies Inc.3.07+0.1+3.37%-- 
KZIAKazia Therapeutics Limited7.98+2.22+38.54%-- 
Quotes are at least 15-min delayed：2025/11/19 11:06 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational sciencehas elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.